{"id":"7a57fe45-96e5-5408-968e-d37dcb379874","stable_key":"10629adf-a816-5b7b-82db-a76bfbb946f2:bg-training-needs-aerobic-glycolysis","predicate":"enables","statement":"Trained monocytes display high glucose consumption, high lactate production and a high ratio of NAD+ to NADH, reflecting a shift in metabolism with an increase in glycolysis dependent on the activation of mammalian target of rapamycin through a dectin-1-Akt-HIF-1 alpha pathway, inhibition of Akt, mTOR or HIF-1 alpha blocked monocyte induction of trained immunity whereas the AMP-activated protein kinase activator metformin inhibited the innate immune response to fungal infection, and mice with a myeloid cell-specific defect in HIF-1 alpha were unable to mount trained immunity against bacterial sepsis.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"bfe04a0a-96bd-52aa-9b32-de65e4421b4a","mechanism_event_label":"The rewiring costs energy: block the cell from burning glucose the fast way and the training does not take.","subject":{"id":"a5bc919c-20f4-57ef-b186-dab7c7addbbd","slug":"glycolysis","display_name":"Glycolysis","entity_type_key":"cellular_process"},"object":{"id":"ee2482e0-2c55-50ac-8daa-085c11fe397d","slug":"trained-immunity","display_name":"Trained immunity, an altered response to a later challenge after the first has ended","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"bfe04a0a-96bd-52aa-9b32-de65e4421b4a","stable_key":"10629adf-a816-5b7b-82db-a76bfbb946f2:bg-training-needs-aerobic-glycolysis-event","event_type":"biochemical_relationship","label":"The rewiring costs energy: block the cell from burning glucose the fast way and the training does not take.","description":"Trained monocytes display high glucose consumption, high lactate production and a high ratio of NAD+ to NADH, reflecting a shift in metabolism with an increase in glycolysis dependent on the activation of mammalian target of rapamycin through a dectin-1-Akt-HIF-1 alpha pathway, inhibition of Akt, mTOR or HIF-1 alpha blocked monocyte induction of trained immunity whereas the AMP-activated protein kinase activator metformin inhibited the innate immune response to fungal infection, and mice with a myeloid cell-specific defect in HIF-1 alpha were unable to mount trained immunity against bacterial sepsis.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"779b2149-a16f-58b8-815b-7f1f2620da1f","slug":"mtor","display_name":"Human mechanistic target of rapamycin kinase / MTOR","entity_type_key":"protein"},"role":"required_kinase","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"22b3e241-94b0-55fd-a233-c63af92520d8","slug":"hif1a","display_name":"HIF-1 alpha","entity_type_key":"protein"},"role":"required_factor","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"a13cb592-c939-5f92-9206-d774248802fc","slug":"akt-proteins","display_name":"AKT serine/threonine kinase family","entity_type_key":"protein_family"},"role":"required_kinase","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"117c178c-d74c-5c56-b2d6-d3956ad70c03","slug":"clec7a","display_name":"Dectin-1 / CLEC7A","entity_type_key":"protein"},"role":"upstream_receptor","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"519971b1-5aef-5ad7-8022-840144855cd0","slug":"metformin","display_name":"Metformin","entity_type_key":"drug"},"role":"inhibiting_drug","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""},{"entity":{"id":"dca88fca-981a-5a11-8a73-997d334bf9d4","slug":"monocyte","display_name":"Monocyte","entity_type_key":"cell_type"},"role":"trained_cell","stoichiometry":null,"state_label":"","sequence_order":5,"notes":""},{"entity":{"id":"a5bc919c-20f4-57ef-b186-dab7c7addbbd","slug":"glycolysis","display_name":"Glycolysis","entity_type_key":"cellular_process"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":6,"notes":""},{"entity":{"id":"ee2482e0-2c55-50ac-8daa-085c11fe397d","slug":"trained-immunity","display_name":"Trained immunity, an altered response to a later challenge after the first has ended","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":7,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/glucan-research/25258083.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"68c4cae9a0e4477a52864e63ecaf5ec977752b5d3246a9ba54aa22d160e41872\", \"start_char\": 0, \"end_char\": 1225, \"text_sha256\": \"68c4cae9a0e4477a52864e63ecaf5ec977752b5d3246a9ba54aa22d160e41872\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Histone modification profiling and genome-wide transcriptome of trained human monocytes, with pathway inhibition and a myeloid conditional knockout","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Beta-glucan training with inhibition of Akt, mTOR or HIF-1 alpha, and metformin as an AMPK activator","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"The metformin result is an experimental inhibition of an induced response, not a clinical interaction study.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Beta-glucan research collection; topical membership is not evidence of a direct clinical effect, and each preparation is recorded as its own entity with no family link joining any pair.","comparator":null,"unit":null,"notes":"","entity":{"slug":"beta-glucan","display_name":"Beta-glucan","entity_type_key":"chemical_species"}},{"dimension":"organism","value_text":"Human cells and mouse","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"The rewiring costs energy: block the cell from burning glucose the fast way and the training does not take.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[bg-p25258083] mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity. (2014). https://pubmed.ncbi.nlm.nih.gov/25258083/ DOI: 10.1126/science.1250684","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Monocyte","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"a474e10a-b94c-5637-843f-bdb07042266f","evidence_kind":"source_excerpt","locator":"Lines 437-448","start_line":437,"end_line":448,"excerpt":"### bg-training-needs-aerobic-glycolysis\nTrained monocytes display high glucose consumption, high lactate production and a high ratio of NAD+ to NADH, reflecting a shift in metabolism with an increase in glycolysis dependent on the activation of mammalian target of rapamycin through a dectin-1-Akt-HIF-1 alpha pathway, inhibition of Akt, mTOR or HIF-1 alpha blocked monocyte induction of trained immunity whereas the AMP-activated protein kinase activator metformin inhibited the innate immune response to fungal infection, and mice with a myeloid cell-specific defect in HIF-1 alpha were unable to mount trained immunity against bacterial sepsis.\nCondition category: normal\nnutrient_topic: Beta-glucan research collection; topical membership is not evidence of a direct clinical effect, and each preparation is recorded as its own entity with no family link joining any pair.\nplain_language: The rewiring costs energy: block the cell from burning glucose the fast way and the training does not take.\norganism: Human cells and mouse\ntissue_or_cell_type: Monocyte\nexperimental_model: Histone modification profiling and genome-wide transcriptome of trained human monocytes, with pathway inhibition and a myeloid conditional knockout\nlimitations: The metformin result is an experimental inhibition of an induced response, not a clinical interaction study.\nexposure: Beta-glucan training with inhibition of Akt, mTOR or HIF-1 alpha, and metformin as an AMPK activator\nevidence_span: {\"source_cache\": \"artifacts/glucan-research/25258083.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"68c4cae9a0e4477a52864e63ecaf5ec977752b5d3246a9ba54aa22d160e41872\", \"start_char\": 0, \"end_char\": 1225, \"text_sha256\": \"68c4cae9a0e4477a52864e63ecaf5ec977752b5d3246a9ba54aa22d160e41872\"}\n[bg-p25258083] mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity. (2014). https://pubmed.ncbi.nlm.nih.gov/25258083/ DOI: 10.1126/science.1250684","model_system":"Histone modification profiling and genome-wide transcriptome of trained human monocytes, with pathway inhibition and a myeloid conditional knockout","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [bg-p25258083] mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity. (2014). https://pubmed.ncbi.nlm.nih.gov/25258083/ DOI: 10.1126/science.1250684","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"74dc223d-8289-57bf-a731-d220fa017c1e","stable_key":"import-10629adf-a816-5b7b-82db-a76bfbb946f2","title":"Beta-glucan: a structural family rather than an agent, what decides whether a bound glucan actually signals, the complement route that a cereal and a yeast preparation share, and the unequal human evidence behind each (2026-09-22)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"7c62f2d2f8d99b650e6dc26a505b0f053ae1c8bdb38099d4dfc0771f65287461","revision_id":"a53bb794-0a4b-525d-9cf7-22b46a5403b0","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}